Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis

  1. Manterola, A.
  2. Bernal-Chico, A.
  3. Cipriani, R.
  4. Ruiz, A.
  5. Pérez-Samartín, A.
  6. Moreno-Rodríguez, M.
  7. Hsu, K.-L.
  8. Cravatt, B.F.
  9. Brown, J.M.
  10. Rodríguez-Puertas, R.
  11. Matute, C.
  12. Mato, S.
Aldizkaria:
Neuropharmacology

ISSN: 1873-7064 0028-3908

Argitalpen urtea: 2018

Alea: 141

Orrialdeak: 181-191

Mota: Artikulua

DOI: 10.1016/J.NEUROPHARM.2018.08.038 GOOGLE SCHOLAR